Researchers at Eli Lilly and Company Target Migraine [The Role of Income and Health Insurance on Migraine Care: Results of the OVERCOME (US) Study]: Primary Headache Diseases and Conditions – Migraine

2026 JAN 23 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Pharma Business Daily -- Investigators publish new report on Primary Headache Diseases and Conditions - Migraine. According to news reporting out of Indianapolis, Indiana, by NewsRx editors, research stated, “Using data from the OVERCOME study, we examined the influence of household income on access to specialty care and use of recommended acute and preventive treatments for migraine in a large population-based study. This analysis from the OVERCOME study, a multicohort, web-based survey (2018-2020) among adults with migraine in the US, examined the influence of annual household income on (1) care-seeking, (2) the highest level of care received (emergency department/urgent care, primary care, specialty care), and (3) use of acute or preventive treatments recommended by the American Headache Society.”

Our news journalists obtained a quote from the research from Eli Lilly and Company, “We used standardized mean differences and logistic regression (LR) models to estimate the magnitude of differences in health care behavior as a function of household income and insurance status. Among OVERCOME (US) respondents with migraine who provided demographic information (n = 56,667), a higher proportion of people in the lowest income group (< $25,000) received their highest level of migraine care in the emergency department/urgent care setting versus the proportion in the highest income group [ $100,000: 12.3% vs 6.5%, standardized mean difference (SMD) = 0.20], and a greater proportion in the highest income group received care in a specialty headache care setting (48.6% vs 36.6% in the lowest income group, SMD = 0.24). The highest income group was more likely to receive a recommended acute treatment [odds ratio (OR) = 1.3, 95% confidence interval (CI) = (1.2, 1.4)] and a recommended preventive treatment [OR = 1.3, 95% CI = (1.2, 1.4)]. Those with health insurance were more likely to receive specialized care [OR = 2.6, 95% CI = (2.4, 2.8)] and recommended acute [OR = 1.9, 95% CI = (1.8, 2.0)] and preventive treatment [OR = 2.1, 95% CI = (1.9, 2.3)]. The effect of insurance was greatest in low-income strata and was not significant in the highest household income group.”

According to the news editors, the research concluded: “Disparities in annual household income may be a barrier to appropriate migraine care, but having health insurance mitigates the effect.”

This research has been peer-reviewed.

For more information on this research see: The Role of Income and Health Insurance on Migraine Care: Results of the OVERCOME (US) Study. Advances In Therapy, 2026. Advances In Therapy can be contacted at: Springer, One New York Plaza, Suite 4600, New York, Ny, United States. (Springer - www.springer.com; Advances In Therapy - http://www.springerlink.com/content/0741-238x/)

Our news journalists report that additional information may be obtained by contacting Betzaida Martinez, Eli Lilly and Company, Indianapolis, IN, United States. Additional authors for this research include Richard B. Lipton, Dawn C. Buse, Ali Sheikhi Mehrabadi, Anthony J. Zagar, Fred Cohen, Robert E. Shapiro, Margaret Hoyt, Sait Ashina, Robert A. Nicholson and E. Jolanda Muenzel.

Publisher contact information for the journal Advances In Therapy is: Springer, One New York Plaza, Suite 4600, New York, Ny, United States.

(Our reports deliver fact-based news of research and discoveries from around the world.)